Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
CME

CME - CME Group Inc Stock Price, Fair Value and News

216.58USD+3.54 (+1.66%)Delayed as of 22 Apr 2024, 01:55 pm ET

Market Summary

CME
USD216.58+3.54
Delayedas of 22 Apr 2024, 01:55 pm
1.66%

CME Alerts

  • 1 major insider buys recently.

CME Stock Price

View Fullscreen

CME RSI Chart

CME Valuation

Market Cap

76.5B

Price/Earnings (Trailing)

23.71

Price/Sales (Trailing)

13.61

EV/EBITDA

16.62

Price/Free Cashflow

22.65

CME Price/Sales (Trailing)

CME Profitability

EBT Margin

71.65%

Return on Equity

12.07%

Return on Assets

2.49%

Free Cashflow Yield

4.42%

CME Fundamentals

CME Revenue

Revenue (TTM)

5.6B

Rev. Growth (Yr)

-59.88%

Rev. Growth (Qtr)

5.19%

CME Earnings

Earnings (TTM)

3.2B

Earnings Growth (Yr)

27.7%

Earnings Growth (Qtr)

8.58%

Breaking Down CME Revenue

52 Week Range

175.73216.62
(Low)(High)

Last 7 days

1.7%

Last 30 days

-0.3%

Last 90 days

5.4%

Trailing 12 Months

11.9%

How does CME drawdown profile look like?

CME Financial Health

Current Ratio

1.02

CME Investor Care

Dividend Yield

3.99%

Dividend/Share (TTM)

8.5

Shares Dilution (1Y)

0.09%

Diluted EPS (TTM)

8.87

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20235.8B7.0B7.6B5.6B
20224.8B3.9B3.5B5.7B
20214.6B4.6B4.6B4.7B
20205.2B5.1B4.9B4.9B
20194.4B4.6B5.0B4.9B
20183.8B4.0B4.0B4.3B
20173.6B3.6B3.7B3.6B
20163.4B3.5B3.5B3.6B
20153.2B3.3B3.4B3.3B
20143.0B2.9B3.0B3.1B
20132.9B2.9B2.9B2.9B
20123.2B3.2B3.0B2.9B
20113.1B3.2B3.3B3.3B
20102.7B2.8B2.9B3.0B
20092.6B2.7B2.6B2.6B
200802.0B2.3B2.6B
20070001.8B
Get all data in R, Python etc through our Historical Stock Data APIs
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of CME Group Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 26, 2024
shepard william r
bought
2,669
214
12.435
-
Mar 26, 2024
shepard william r
bought
60,561
214
282
-
Mar 15, 2024
fitzpatrick lynne
sold (taxes)
-71,557
217
-329
sr md chief financial officer
Mar 15, 2024
tobin jack j
acquired
117,668
217
541
md chief accounting officer
Mar 15, 2024
winkler julie
sold (taxes)
-619,222
217
-2,847
sr md chief commercial officer
Mar 15, 2024
winkler julie
acquired
1,397,440
217
6,425
sr md chief commercial officer
Mar 15, 2024
cutinho sunil
acquired
1,562,300
217
7,183
chief information officer
Mar 15, 2024
holzrichter julie
sold (taxes)
-728,625
217
-3,350
sr md chief operating officer
Mar 15, 2024
holzrichter julie
acquired
1,644,300
217
7,560
sr md chief operating officer
Mar 15, 2024
piell hilda harris
sold (taxes)
-566,152
217
-2,603
sr md & chief hr officer

1–10 of 50

Which funds bought or sold CME recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 18, 2024
Oak Thistle LLC
new
-
587,311
587,311
 0.53%
Apr 18, 2024
Aviance Capital Partners, LLC
new
-
525,308
525,308
 0.08%
Apr 18, 2024
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P.
sold off
-100
-
-
 -%
Apr 18, 2024
Miracle Mile Advisors, LLC
added
11.47
94,176
769,789
 0.02%
Apr 18, 2024
Congress Wealth Management LLC / DE /
added
2.25
1,027,150
23,721,100
 0.41%
Apr 18, 2024
BKM Wealth Management, LLC
sold off
-100
-8,634
-
 -%
Apr 18, 2024
Applied Capital LLC/FL
added
0.51
59,721
1,194,640
 0.97%
Apr 18, 2024
AEGON ASSET MANAGEMENT UK Plc
reduced
-16.33
-16,500,000
97,272,000
 1.46%
Apr 18, 2024
WOLFF WIESE MAGANA LLC
unchanged
-
24.00
1,077
 -%
Apr 18, 2024
CULLINAN ASSOCIATES INC
reduced
-0.26
15,857
824,561
 0.05%

1–10 of 50

Are Funds Buying or Selling CME?

Are funds buying CME calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CME
No. of Funds

CME Alerts

Unveiling CME Group Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
9.29%
33,450,782
SC 13G/A
Jan 26, 2024
blackrock inc.
6.7%
23,991,739
SC 13G/A
Feb 13, 2023
capital world investors
4.4%
15,768,261
SC 13G/A
Feb 09, 2023
vanguard group inc
9.21%
33,139,178
SC 13G/A
Jan 31, 2023
blackrock inc.
7.2%
26,025,197
SC 13G/A
Feb 11, 2022
capital world investors
9.3%
33,473,618
SC 13G/A
Feb 09, 2022
vanguard group inc
8.72%
31,356,965
SC 13G/A
Feb 03, 2022
blackrock inc.
6.7%
24,162,418
SC 13G/A
Feb 16, 2021
capital world investors
9.5%
33,945,618
SC 13G/A
Feb 10, 2021
vanguard group inc
7.86%
28,231,615
SC 13G/A

Recent SEC filings of CME Group Inc

View All Filings
Date Filed Form Type Document
Apr 03, 2024
4/A
Insider Trading
Mar 27, 2024
4
Insider Trading
Mar 22, 2024
4
Insider Trading
Mar 21, 2024
DEFA14A
DEFA14A
Mar 19, 2024
4
Insider Trading
Mar 19, 2024
4
Insider Trading
Mar 19, 2024
4
Insider Trading
Mar 19, 2024
4
Insider Trading
Mar 19, 2024
4
Insider Trading
Mar 19, 2024
4
Insider Trading

Peers (Alternatives to CME Group Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
GS
131.5B
68.5B
 1.90% 19.28%
15.45
1.92
 136.06% -24.38%
CME
76.5B
5.6B
 -0.27% 11.92%
23.71
13.61
 -0.62% 19.89%
ICE
75.1B
9.9B
 -3.59% 21.76%
31.73
7.59
 2.77% 63.76%
COIN
49.7B
3.1B
 -17.89% 248.64%
524.25
16
 -2.69% 103.61%
FDS
16.6B
2.2B
 -10.99% 4.21%
33.83
7.69
 7.26% 9.28%
IBKR
11.7B
6.2B
 2.57% 36.31%
4.17
1.88
 131.94% 52.66%
MID-CAP
JEF
8.9B
8.2B
 -5.91% 34.53%
34.08
1.09
 17.04% -76.58%
HLI
8.0B
1.8B
 -0.30% 32.14%
30.72
4.33
 0.16% -0.33%
EVR
7.1B
2.4B
 -2.96% 51.37%
27.79
2.91
 -12.10% -46.39%
FRHC
3.9B
1.4B
 -9.70% -10.04%
11.64
2.79
 96.15% 398.80%
CLSK
3.4B
214.4M
 -15.06% 341.03%
-41.72
15.89
 75.40% 19.03%
SMALL-CAP
DFIN
1.8B
797.2M
 -0.03% 38.82%
22.02
2.27
 -4.37% -19.80%
AMRK
868.0M
10.0B
 31.93% 6.84%
7.86
0.09
 24.24% -27.96%
COHN
12.1M
83.0M
 -16.84% -5.22%
-2.06
0.15
 15.07% 81.87%
AAMC
7.7M
3.2M
 -15.69% -96.37%
-0.24
2.43
 -44.67% -104.26%

CME Group Inc News

Latest updates
MarketWatch • 19 Apr 2024 • 08:46 pm
CME Group Inc. Cl A stock outperforms competitors on strong trading day
Yahoo Finance Australia • 19 Apr 2024 • 04:34 pm
Here's What to Expect From CME Group (CME) in Q1 Earnings
Seeking Alpha • 18 Apr 2024 • 11:56 am
CME Group Stock: A Sleep Well At Night Company To Own (NASDAQ:CME)
Simply Wall St • 18 Apr 2024 • 10:32 am
CME Group Inc. (NASDAQ:CME) is a favorite amongst institutional investors who own 89%
Yahoo Finance • 17 Apr 2024 • 02:01 pm
CME Group (CME) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Nasdaq • 05 Apr 2024 • 07:00 am
Here's Why You Should Hold CME Group (CME) Stock for Now
CNN • 14 Mar 2024 • 08:30 pm
CME Stock Quote Price and Forecast
CME Group • 2 months ago
CME Group Inc. Reports Fourth-Quarter and Full-Year 2023 Financial Results
Forbes • 4 months ago
Up 26% YTD, What's Next For CME Group Stock?
CME Group • 4 months ago
CME Group Declares Annual Variable Dividend

CME Group Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue5.2%1,3391,2731,5681,4423,3366862871,3471,1471,1101,1791,2531,0991,0811,1821,5221,1381,2771,2731,1801,237
Costs and Expenses11.3%576518522528540489488488516496505528584556545562565592574549587
EBITDA Margin-0.76*-0.59*0.70*0.66*1.08*1.02*0.80*0.78*0.67*0.67*0.67*0.63*0.63*0.64*0.64*0.62*0.60*0.62*0.65*0.70*
Income Taxes-14.6%19122423927318920020420517417021617811012515822315587.00188144284
Earnings Before Taxes-100.0%-9741,0161,157-880867916-1,096726752-537661989624723702640671
EBT Margin35.5%0.72*0.53*0.55*0.65*0.62*1.00*0.95*0.74*0.72*0.61*0.61*0.61*0.58*0.57*0.59*0.58*0.55*0.55*0.56*0.60*0.64*
Net Income8.6%815750778884638680663711625927510574424412503766470636514497386
Net Income Margin43.4%0.57*0.40*0.42*0.50*0.48*0.77*0.75*0.58*0.56*0.52*0.42*0.41*0.43*0.44*0.46*0.46*0.43*0.41*0.39*0.42*0.46*
Free Cashflow22.3%1,024837630887957634600776641600460574590263950714653753401620455
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets3.3%129,706125,598151,297166,039174,176178,432176,671205,918196,780186,774178,699160,652124,660125,759117,215137,93275,21579,41870,35071,61577,476
  Current Assets4.5%94,89090,777116,366131,032139,078143,253141,451171,004161,762151,594144,849126,74689,28490,34981,786102,41739,56843,69234,46235,60541,887
    Cash Equivalents26.6%2,9122,3001,8801,5652,7202,1301,8802,0462,8351,4591,08193688,4201,3321,40585238,6341,21093899740,833
  Net PPE-1.9%410417430440456466482494505521528529579547539538544517500468449
  Goodwill0.2%10,49510,47810,49110,49110,48310,44710,48410,51610,52810,52910,54310,53410,79910,75610,74310,74310,74310,77410,79510,85010,805
Liabilities5.7%102,96897,447123,479138,655147,297150,181148,670178,181169,381159,492151,912134,09698,30898,74890,376111,33449,05652,60443,86545,42851,510
  Current Liabilities6.3%93,41787,881113,886129,044137,688140,573139,000168,459160,398150,417142,013124,22388,19888,63180,201101,05438,52341,91432,93534,27241,273
  Short Term Borrowings----16.0016.0015.00--749749----------574
Shareholder's Equity-5.0%26,73828,15222,31122,28526,87928,25128,00227,73727,39927,28226,78726,55626,35227,01026,83926,59926,15926,81326,48526,18725,965
  Retained Earnings-25.2%4,4555,9565,6075,2304,7476,1125,7985,4995,1526,0375,4355,2474,9965,7755,6695,4705,0095,7045,3375,0914,855
  Additional Paid-In Capital0.1%22,33522,30922,30822,28222,26222,23522,23222,20622,19021,20421,21921,19421,18621,15721,14921,12021,11321,10821,10921,06221,054
Accumulated Depreciation-100.0%-9048741,1751,1451,1111,0971,0711,0391,046980947961932894886868837844790761
Shares Outstanding0.0%359359359359359359359359358358358358358358358358357357357357342
Minority Interest-----------24.0028.0032.0031.0031.0031.0030.0030.0030.0029.0047.00
Float---66,300---73,200---76,000---57,900---68,500--
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations21.9%1,044857650902982658618799668632500603660311987757720810474669510
  Share Based Compensation28.6%24.0019.0020.0020.0026.0019.0019.0020.0019.0016.0019.0022.0027.0024.0022.0023.002.0014.0038.0018.0046.00
Cashflow From Investing-4.6%-20.40-19.5078.00-17.20-25.70-23.60-417-22.9068.0059.00-34.00-34.00-52.10-43.90-36.50-43.00-15.90-46.80-41.30-48.60-1,850
Cashflow From Financing109.8%2,589-26,466-15,262-9,198-5,0911,161-29,6728,2229,3957,55017,56535,39949,398-340-396-1,413-363-490-489-997-312
  Dividend Payments0.0%4004004002,0363643633631,5443273233231,2183043043041,198268268268892250

CME Income Statement

2023-12-31
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues   
Total Revenues$ 5,578.9$ 5,019.4$ 4,689.7
Expenses   
Compensation and benefits828.6753.1837.0
Technology218.7188.6192.6
Professional fees and outside services144.4137.4151.7
Amortization of purchased intangibles226.6227.7237.6
Depreciation and amortization126.0134.9147.8
Licensing and other fee agreements322.8320.0236.9
Other276.1241.8240.9
Total Expenses2,143.22,003.52,044.5
Operating Income3,435.73,015.92,645.2
Non-Operating Income (Expense)   
Investment income5,275.32,198.4306.9
Interest and other borrowing costs(159.4)(162.7)(166.9)
Equity in net earnings (losses) of unconsolidated subsidiaries296.9301.1245.8
Other income (expense)(4,694.9)(1,862.4)342.6
Total Non-Operating717.9474.4728.4
Income before Income Taxes4,153.63,490.33,373.6
Income tax provision927.4799.3736.7
Net income3,226.22,691.02,636.9
Net Income (Loss) Attributable to Noncontrolling Interest0.00.00.5
Net income attributable to CME Group3,226.22,691.02,636.4
Net Income Attributable to Common Shareholders of CME Group$ 3,185.6$ 2,657.2$ 2,617.1
Earnings per Common Share Attributable to CME Group:   
Basic$ 8.87$ 7.41$ 7.30
Diluted$ 8.86$ 7.40$ 7.29
Weighted Average Number of Common Shares:   
Basic359,023358,713358,340
Diluted359,500359,181358,929
Clearing and Transaction Fees [Member]   
Revenues   
Total Revenues$ 4,588.5$ 4,142.7$ 3,765.1
MarketData [Member]   
Revenues   
Total Revenues663.7610.9576.9
OtherRevenue [Member]   
Revenues   
Total Revenues$ 326.7$ 265.8$ 347.7

CME Balance Sheet

2023-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Assets  
Cash and cash equivalents$ 2,912.0$ 2,720.1
Marketable securities111.796.0
Accounts receivable, net of allowance535.6483.2
Other current assets1,138.4529.8
Performance bonds and guaranty fund contributions90,192.5135,249.2
Total current assets94,890.2139,078.3
Property, net of accumulated depreciation and amortization409.5455.5
Intangible assets-trading products[1]17,175.317,175.3
Intangible assets—other, net3,050.23,269.7
Goodwill10,495.310,482.5
Other assets3,685.63,714.4
Total Assets129,706.1174,175.7
Liabilities and Shareholders' Equity  
Accounts payable90.6121.4
Short-term debt0.016.0
Other current liabilities3,133.82,300.9
Performance bonds and guaranty fund contributions90,192.5135,249.2
Total current liabilities93,416.9137,687.5
Long-term debt3,425.43,422.4
Deferred Income Tax Liabilities, Net5,327.75,361.1
Other liabilities798.2826.0
Total Liabilities102,968.2147,297.0
Shareholders' Equity:  
Preferred stock, $0.01 par value, 10,000 shares authorized, none issued or outstanding0.00.0
Additional paid-in capital22,334.722,261.6
Retained earnings4,455.24,746.8
Accumulated other comprehensive income (loss)(55.6)(133.3)
Total CME Group Shareholders' Equity26,737.926,878.7
Total Liabilities and Shareholders' Equity129,706.1174,175.7
Class A Common Stock (Shares) [Member]  
Shareholders' Equity:  
Common stock3.63.6
Class B Common Stock (Shares) [Member]  
Shareholders' Equity:  
Common stock$ 0.0$ 0.0
[1]Trading products represent futures and options products acquired in our business combinations with CBOT Holdings, Inc., NYMEX Holdings, Inc. and The Board of Trade of Kansas City, Missouri, Inc. Clearing and transaction fees are generated through the trading of these products. These trading products, most of which have traded for decades, require authorization from the CFTC. Product authorizations from the CFTC have no term limits.

About CME Group Inc

CME
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.
 CEO
 WEBSITEcmegroup.com
 INDUSTRYMortgage Finance
 EMPLOYEES3460

CME Group Inc Frequently Asked Questions

What is the ticker symbol for CME Group Inc? What does CME stand for in stocks?

CME is the stock ticker symbol of CME Group Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of CME Group Inc (CME)?

As of Fri Apr 19 2024, market cap of CME Group Inc is 76.49 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CME stock?

You can check CME's fair value in chart for subscribers.

What is the fair value of CME stock?

You can check CME's fair value in chart for subscribers. The fair value of CME Group Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of CME Group Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CME so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is CME Group Inc a good stock to buy?

The fair value guage provides a quick view whether CME is over valued or under valued. Whether CME Group Inc is cheap or expensive depends on the assumptions which impact CME Group Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CME.

What is CME Group Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 19 2024, CME's PE ratio (Price to Earnings) is 23.71 and Price to Sales (PS) ratio is 13.61. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CME PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on CME Group Inc's stock?

In the past 10 years, CME Group Inc has provided 0.156 (multiply by 100 for percentage) rate of return.